Direct and indirect costs among employees with diabetic retinopathy in the United States
- 8 April 2008
- journal article
- research article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 24 (5), 1549-1559
- https://doi.org/10.1185/030079908x297303
Abstract
Objective: To examine, from the employer perspective, the direct (healthcare) and indirect (workloss) costs of employees with diabetic retinopathy (DR) compared to control non-DR employees with diabetes, and within DR subgroups. Methods: Compared annual costs using claims data from 17 large companies (1999–2004). ‘DR employees’ (n = 2098) had ≥ 1 DR (International Classification of Disease, 9th Revision [ICD‑9]) diagnosis; DR subgroups included employees with diabetic macular edema (DME), proliferative DR (PDR), and employees receiving photocoagulation or vitrectomy procedures. Descriptive and multivariate tests were performed. Results: DR employee annual direct costs were $18 218 (indirect = $3548) compared to $11 898 (indirect = $2374) for controls (Δ = $2032 (adjusted); p < 0.0001). Costs differences were larger across DR employee subgroups: DME/non-DME ($28 606/$16 363); PDR/non-PDR ($30 135/$13 445; p < 0.0001); DR with/without photocoagulation ($34 539/$16 041; p < 0.0001); and DR with/without vitrectomy ($63 933/$17 239; p < 0.0001). Limitations: This study examined the incremental costs of treating DR employees, which may be higher than the incremental costs of DR itself. Some measures of diabetes severity (e.g., duration of diabetes) were not available in the claims data, and were therefore not included in the multivariate models. The cost of photocoagulation and vitrectomy procedures pertain to individuals who underwent these procedures, and not the cost of the procedures themselves. Conclusion: DR employees had significantly higher costs than controls, and larger differences existed within DR subgroups. Indirect costs accounted for about 20% of total cost.Keywords
This publication has 21 references indexed in Scilit:
- Economic Costs of Diabetes in the U.S. in 2007Diabetes Care, 2008
- The Economic Burden of Major Adult Visual Disorders in the United StatesAmerican Journal of Ophthalmology, 2006
- Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. PopulationDiabetes Care, 2006
- Diabetic RetinopathyDiabetes Care, 2004
- Causes and Prevalence of Visual Impairment Among Adults in the UnitedStatesAmerican Journal of Ophthalmology, 2004
- Cost of Stress Urinary IncontinencePharmacoEconomics, 2004
- The Wisconsin epidemiologic study of diabetic retinopathy: XVII: The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetesOphthalmology, 1998
- Cost-Effectiveness of Detecting and Treating Diabetic RetinopathyAnnals of Internal Medicine, 1996
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Incidence of Diabetic Retinopathy and Blindness: A Population-based Study in Rochester, MinnesotaDiabetes Care, 1985